TrialBritish journal of clinical pharmacology2016

Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.

Wenying Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.